Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Humacyte Inc (HUMA)

Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 571,603
  • Shares Outstanding, K 119,084
  • Annual Sales, $ 0 K
  • Annual Income, $ -110,780 K
  • 60-Month Beta 1.62
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 21.40
Trade HUMA with:

Options Overview Details

View History
  • Implied Volatility 142.31% ( +5.10%)
  • Historical Volatility 114.19%
  • IV Percentile 92%
  • IV Rank 43.86%
  • IV High 305.42% on 06/30/23
  • IV Low 14.89% on 12/06/23
  • Put/Call Vol Ratio 0.25
  • Today's Volume 689
  • Volume Avg (30-Day) 2,774
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 35,707
  • Open Int (30-Day) 35,541

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.23
  • Number of Estimates 1
  • High Estimate -0.23
  • Low Estimate -0.23
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -4.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.60 +4.35%
on 06/28/24
9.97 -51.86%
on 05/31/24
-2.69 (-35.91%)
since 05/28/24
3-Month
2.81 +70.82%
on 04/12/24
9.97 -51.86%
on 05/31/24
+1.69 (+54.34%)
since 03/28/24
52-Week
1.96 +144.90%
on 11/01/23
9.97 -51.86%
on 05/31/24
+1.77 (+58.42%)
since 06/28/23

Most Recent Stories

More News
This Surging Small-Cap Biotech Has One Very High-Profile Investor

Humacyte is a pre-revenue biotech company that has delivered outsized gains to shareholders in 2024. But is the small-cap stock a good buy right now?

HUMA : 4.80 (+2.13%)
Last month, we reported on a suspicious stock trade by a U.S. Senator. The stock has now risen 220% since then.

On April 16th, we reported on a stock trade by Senator Tommy Tuberville that looked suspicious to us. The stock has now risen 220% in the month since then. The stock in question was Humacyte, $HUMA. It's...

HUMA : 4.80 (+2.13%)
Insiders, hedge funds, and politicians trading Humacyte stock (NDAQ:HUMA) in Q1 2024

$HUMA earnings were just released. Here is a look at recent trades of $HUMA by people who might have an edge.CongressMembers of Congress have disclosed trades of $HUMA stock 5 times in the last quarter....

HUMA : 4.80 (+2.13%)
U.S. Senator Tommy Tuberville Just Reported a Purchase of $HUMA stock

In a new disclosure filed today, U.S. Senator Tommy Tuberville reported the purchase of $1,001 - $15,000 of Humacyte Inc, in a trade that took place on March 21. Since that trade was made, the stock has...

HUMA : 4.80 (+2.13%)
Fed Speaks, Canada Inflation on Lineup Next Week

Monday U.S. Economic Lookahead Home builder confidence index (Feb.) Featured Earnings ...

AOT.TO : 0.56 (+13.13%)
FLOW.TO : 0.2200 (+2.33%)
SMT.TO : 0.76 (-3.80%)
DD : 80.49 (+0.64%)
CNM : 48.94 (-0.20%)
HQY : 86.20 (+2.25%)
HUMA : 4.80 (+2.13%)
BRNS : 1.4000 (+1.08%)
Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications

Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a definitive business combination agreement...

ALPA : 9.80 (+0.10%)
DMTK : 0.0940 (-11.32%)
HUMA : 4.80 (+2.13%)
Humacyte to Present Second Quarter 2022 Financial Results and Provide Recent Corporate Update on August 12, 2022

DURHAM, N.C., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally...

HUMA : 4.80 (+2.13%)
Humacyte Preclinical Data on Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary Artery Bypass Grafting (CABG) Presented at American Heart Association Meeting

-- Preclinical model data expected to support development of small diameter HAV to treat patients with coronary artery disease-- -- Small-diameter HAV...

HUMA : 4.80 (+2.13%)
Humacyte Hosting Key Opinion Leader Webinar on Human Acellular Vessels™ in the Treatment of Vascular Trauma

Thursday, July 14, 2022 @ 11:30 a.m. ET...

HUMA : 4.80 (+2.13%)
Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.

Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companies...

HUMA : 4.80 (+2.13%)

Business Summary

Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 5.20
2nd Resistance Point 5.04
1st Resistance Point 4.92
Last Price 4.80
1st Support Level 4.64
2nd Support Level 4.48
3rd Support Level 4.36

See More

52-Week High 9.97
Fibonacci 61.8% 6.91
Fibonacci 50% 5.97
Fibonacci 38.2% 5.02
Last Price 4.80
52-Week Low 1.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar